semaglutide life extension Weight Management GLP-1 Agonists for Diabetes, Obesity,

GLP-1, or glucagon-like peptide-1, is an incretin hormone produced primarily by enteroendocrine L cells in the small intestine and colon

nordicum A

The US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly

Larger and longer trials of semaglutide and other drugs in its class are already underway, noted Dr

The coding landscape for tirzepatide has shifted considerably since the FDA approved Zepbound for chronic weight management alongside Mounjaro for type 2 diabetes

#Biosimilars play a critical role in making advanced treatments more affordable and widely available - especially in markets like India, where scale and access matter deeply